Healthcare provider profile · identity verified

Edwin Rodriguez Ramos, MD

General Practice · JUNCOS, PR · NPI 1669459699

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	509	129
Famotidine	Famotidine	454	138
Atorvastatin Calcium	Atorvastatin Calcium	411	148
Clonazepam	Clonazepam	309	53
Losartan Potassium	Losartan Potassium	296	97
Metformin Hcl	Metformin Hcl	294	90
Diclofenac Sodium	Diclofenac Sodium	271	98
Omeprazole	Omeprazole	253	80
Lisinopril	Lisinopril	198	62
Azithromycin	Azithromycin	193	147
Synthroid	Levothyroxine Sodium	191	55
Methylprednisolone	Methylprednisolone	184	133
Pantoprazole Sodium	Pantoprazole Sodium	179	50
Levothyroxine Sodium	Levothyroxine Sodium	166	49
Simvastatin	Simvastatin	159	50
Pravastatin Sodium	Pravastatin Sodium	150	48
Amlodipine Besylate	Amlodipine Besylate	148	51
Hydrochlorothiazide	Hydrochlorothiazide	128	46
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	106	72
Diclofenac Potassium	Diclofenac Potassium	103	56
Tramadol Hcl	Tramadol Hcl	100	16
Tamsulosin Hcl	Tamsulosin Hcl	92	33
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	86	suppressed
Glipizide	Glipizide	85	26
Clopidogrel	Clopidogrel Bisulfate	82	27
Lantus	Insulin Glargine,hum.Rec.Anlog	81	21
Furosemide	Furosemide	79	30
Alendronate Sodium	Alendronate Sodium	75	21
Metoprolol Succinate	Metoprolol Succinate	75	24
Metoprolol Tartrate	Metoprolol Tartrate	66	21
Rosuvastatin Calcium	Rosuvastatin Calcium	66	25
Montelukast Sodium	Montelukast Sodium	64	23
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	63	11
Carvedilol	Carvedilol	60	21
Tizanidine Hcl	Tizanidine Hcl	60	11
Alprazolam	Alprazolam	59	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	57	26
Enalapril Maleate	Enalapril Maleate	57	18
Farxiga	Dapagliflozin Propanediol	57	17
Temazepam	Temazepam	57	11
Glimepiride	Glimepiride	56	17
Donepezil Hcl	Donepezil Hcl	55	22
Lansoprazole	Lansoprazole	55	14
Nabumetone	Nabumetone	55	27
Dicyclomine Hcl	Dicyclomine Hcl	54	18
Fluticasone Propionate	Fluticasone Propionate	53	21
Latanoprost	Latanoprost	53	11
Levofloxacin	Levofloxacin	52	46
Lorazepam	Lorazepam	49	12
Finasteride	Finasteride	48	16
Eliquis	Apixaban	47	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	13
Memantine Hcl	Memantine Hcl	43	13
Atenolol	Atenolol	42	11
Irbesartan	Irbesartan	42	12
Naproxen	Naproxen	38	20
Humulin N	Insulin Nph Human Isophane	36	suppressed
Nifedipine Er	Nifedipine	36	11
Jardiance	Empagliflozin	35	16
Cefadroxil	Cefadroxil	33	33
Ezetimibe	Ezetimibe	32	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	31	15
Doxepin Hcl	Doxepin Hcl	30	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	29	suppressed
Allopurinol	Allopurinol	28	suppressed
Glipizide Er	Glipizide	28	suppressed
Betamethasone Valerate	Betamethasone Valerate	27	13
Verapamil Er	Verapamil Hcl	27	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Sucralfate	Sucralfate	26	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	25	suppressed
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Sertraline Hcl	Sertraline Hcl	24	suppressed
Sure Comfort	Syringe And Needle,insulin,1ml	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	18
Insulin Syringe	Syringe And Needle,insulin,1ml	21	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	21	suppressed
Meclizine Hcl	Meclizine Hcl	20	15
Sildenafil Citrate	Sildenafil Citrate	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Trazodone Hcl	Trazodone Hcl	19	suppressed
Baclofen	Baclofen	18	suppressed
Humalog	Insulin Lispro	18	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	18	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Raloxifene Hcl	Raloxifene Hcl	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	13
Bumetanide	Bumetanide	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	17	17
Orphenadrine Citrate Er	Orphenadrine Citrate	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Sure Comfort	Syringe-Needle,insulin,0.5 Ml	16	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	14	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	14	suppressed
Fluconazole	Fluconazole	14	13
Ibuprofen	Ibuprofen	14	suppressed
Pentoxifylline	Pentoxifylline	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Tradjenta	Linagliptin	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Anastrozole	Anastrozole	11	suppressed
Bicalutamide	Bicalutamide	11	suppressed
Colchicine	Colchicine	11	suppressed
Etodolac	Etodolac	11	suppressed
Humulin R	Insulin Regular, Human	11	suppressed
Repatha Sureclick	Evolocumab	11	suppressed
Risperidone	Risperidone	11	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	11	suppressed
Timolol Maleate	Timolol Maleate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error